As the prevalence of #CAD increases, so does the need for better risk assessment.
Circulating #microRNAs (miRNAs) are promising emerging #biomarkers. Here, @Ellie_Chip17 et al. discuss their role in CAD risk stratification and prognosis π https://t.co/3cbKzP2SVB
#ECRJournal